{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:33:09Z","timestamp":1793741589142,"version":"4.6.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:00:00Z","timestamp":1711843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.msard.2024.105596","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T23:48:05Z","timestamp":1711842485000},"page":"105596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: A narrative review"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6737-5489","authenticated-orcid":false,"given":"Christina","family":"Kazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Alpitsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Malpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-9768","authenticated-orcid":false,"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105596_bib0001","article-title":"Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis","volume":"70","author":"Ashtari","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2024.105596_bib0002","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/ene.14729","article-title":"Pain, depression, and quality of life in adults with MOG-antibody-associated disease","volume":"28","author":"Asseyer","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105596_bib0003","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000985","article-title":"Pain, depression, and quality of life in neuromyelitis optica spectrum disorder: a cross-sectional study of 166 AQP4 antibody-seropositive patients","volume":"8","author":"Ayzenberg","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105596_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.msard.2019.01.053","article-title":"MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis","volume":"30","author":"Baba","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105596_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0006","first-page":"44","article-title":"Clinical and psychometrical study of a patient with memory disturbances","volume":"7","author":"Barbizet","year":"1968","journal-title":"Int. J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.105596_bib0007","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archneur.1978.00500300038006","article-title":"Visuospatial judgment: a clinical test","volume":"35","author":"Benton","year":"1978","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.105596_bib0008","doi-asserted-by":"crossref","first-page":"e33878","DOI":"10.1371\/journal.pone.0033878","article-title":"White matter atrophy and cognitive dysfunctions in neuromyelitis optica","volume":"7","author":"Blanc","year":"2012","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneurol.2007.16","article-title":"Cognitive functions in neuromyelitis optica","volume":"65","author":"Blanc","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2024.105596_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117088","article-title":"Unfavorable outcome in highly relapsing MOGAD encephalitis","volume":"418","author":"Buciuc","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2024.105596_bib0011","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11065-017-9343-7","article-title":"Long-term neuropsychological outcomes of childhood onset acute disseminated encephalomyelitis (ADEM): a meta-analysis","volume":"27","author":"Burton","year":"2017","journal-title":"Neuropsychol. Rev."},{"issue":"11","key":"10.1016\/j.msard.2024.105596_bib0012","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.24.11.1019","article-title":"Evaluating storage, retention, and retrieval in disordered memory and learning","volume":"24","author":"Buschke","year":"1974","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp-2021-327206","article-title":"Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders","volume":"93","author":"Camera","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2024.105596_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102428","article-title":"Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice","volume":"45","author":"Carnero Contentti","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105596_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102406","article-title":"Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders","volume":"45","author":"Chavarro","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2024.105596_bib0016","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1212\/NXI.0000000000000286","article-title":"Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder","volume":"3","author":"Chavarro","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105596_bib0017","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fneur.2018.01104","article-title":"White matter network disruption and cognitive dysfunction in neuromyelitis optica spectrum disorder","volume":"9","author":"Cho","year":"2018","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105596_bib0018","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/2211-5056.355617","article-title":"What's new in neuromyelitis optica spectrum disorder treatment?","volume":"12","author":"Chu","year":"2022","journal-title":"Taiwan. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.msard.2024.105596_bib0019","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/dmcn.14594","article-title":"Risk factors for academic difficulties in children with myelin oligodendrocyte glycoprotein antibody-associated acute demyelinating syndromes","volume":"62","author":"Deiva","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/0022-006X.56.1.123","article-title":"Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test","volume":"56","author":"Delis","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"issue":"5","key":"10.1016\/j.msard.2024.105596_bib0021","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/ene.14746","article-title":"The long-term outcome of MOGAD: an observational national cohort study of 61 patients","volume":"28","author":"Deschamps","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0035-3787(04)70847-4","article-title":"[BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis]","volume":"160","author":"Dujardin","year":"2004","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.msard.2024.105596_bib0023","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.msard.2017.07.014","article-title":"Patient perspectives on neuromyelitis optica spectrum disorders: data from the PatientsLikeMe online community","volume":"17","author":"Eaneff","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105596_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103689","article-title":"Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"59","author":"Fabri","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105596_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.msard.2017.11.002","article-title":"Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina","volume":"19","author":"Fern\u00e1ndez","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2024.105596_bib0026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.msard.2024.105596_bib0027","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.msard.2024.105596_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ensci.2017.09.001","article-title":"Cognitive impairment in neuromyelitis optica spectrum disorders: a comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery","volume":"9","author":"Fujimori","year":"2017","journal-title":"eNeurologicalSci."},{"key":"10.1016\/j.msard.2024.105596_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(22)00520-8","article-title":"MOGAD comes of age with new criteria","author":"Graus","year":"2023","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105596_bib0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1037\/a0026712","article-title":"Age group and sex differences in performance on a computerized neurocognitive battery in children age 8\u2212 21","volume":"26","author":"Gur","year":"2012","journal-title":"Neuropsychology."},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0031","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bandc.2011.05.007","article-title":"Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse","volume":"77","author":"He","year":"2011","journal-title":"Brain Cogn."},{"key":"10.1016\/j.msard.2024.105596_bib0032","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2016.01.010","article-title":"Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder","volume":"362","author":"Hollinger","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"14","key":"10.1016\/j.msard.2024.105596_bib0033","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1177\/1352458516636246","article-title":"Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"22","author":"Kim","year":"2016","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0034","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1038\/s41598-017-08889-9","article-title":"Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.msard.2024.105596_bib0035","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1212\/WNL.0000000000203034","article-title":"Cognitive sequelae in MOG antibody-associated disease (P13-5.025)","volume":"100","author":"Li","year":"2023","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.msard.2024.105596_bib0036","first-page":"12","article-title":"Cognitive performance and health-related quality of life in patients with neuromyelitis optica spectrum disorder","author":"Lopez-Soley","year":"2022","journal-title":"J. Pers. Med."},{"issue":"8","key":"10.1016\/j.msard.2024.105596_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184012","article-title":"Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"12","author":"Masuda","year":"2017","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2024.105596_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102757","article-title":"The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis","volume":"49","author":"Moghadasi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105596_bib0039","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2015.11.031","article-title":"Cognitive and psychiatric comorbidities in neuromyelitis optica","volume":"360","author":"Moore","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2024.105596_bib0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.msard.2024.105596_bib0041","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/cen3.12528","article-title":"Cognitive impairment as one of the important non-motor symptoms in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"10","author":"Niino","year":"2019","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.msard.2024.105596_bib0042","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fneur.2019.00608","article-title":"Cognitive impairment in neuromyelitis optica spectrum disorders: a review of clinical and neuroradiological features","volume":"10","author":"Oertel","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.105596_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104168","article-title":"The prevalence, demographics, clinical features, neuroimaging, and inter-ethnic differences of MOGAD in Malaysia with global perspectives","volume":"67","author":"Ong","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105596_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103884","article-title":"Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy","volume":"63","author":"Orlandi","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105596_bib0045","article-title":"Le test de copie d'une figure complexe; contribution a l'etude de la perception et de la memoire","author":"Osterrieth","year":"1944","journal-title":"Arch. Psychol. (Geneve)"},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0046","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.12786\/bn.2022.15.e9","article-title":"Multidisciplinary rehabilitation for relapsing myelin oligodendrocyte glycoprotein antibody-associated disease: a case report","volume":"15","author":"Park","year":"2022","journal-title":"Brain Neurorehabil."},{"issue":"4","key":"10.1016\/j.msard.2024.105596_bib0047","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.rdc.2017.06.007","article-title":"Neuromyelitis optica","volume":"43","author":"Patterson","year":"2017","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.msard.2024.105596_bib0048","doi-asserted-by":"crossref","unstructured":"Person, M., & Becke, M. (2021). Translational research in neuroimmunology: cognition. In (pp. 171\u2013182). Springer US. https:\/\/doi.org\/10.1007\/978-1-0716-1213-2_12.","DOI":"10.1007\/978-1-0716-1213-2_12"},{"key":"10.1016\/j.msard.2024.105596_bib0049","first-page":"1696","article-title":"A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis","author":"Rao","year":"1990","journal-title":"Milwaukee: Med. Coll. Wisconsin"},{"issue":"6","key":"10.1016\/j.msard.2024.105596_bib0050","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archneur.1984.04210080033010","article-title":"Memory disturbance in chronic progressive multiple sclerosis","volume":"41","author":"Rao","year":"1984","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2024.105596_bib0051","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.41.5.692","article-title":"Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105596_bib0052","first-page":"286","article-title":"L'examen psychologique dans les cas d'encephalopathie traumatique","volume":"28","author":"Rey","year":"1941","journal-title":"Arch. Psychol. (Geneve)"},{"key":"10.1016\/j.msard.2024.105596_bib0053","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.msard.2017.09.015","article-title":"Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: a consensus guideline and recommendations","volume":"18","author":"Sahraian","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0054","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.23721","article-title":"Cognitive impairment and cortical degeneration in neuromyelitis optica","volume":"73","author":"Saji","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2024.105596_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105621","article-title":"Cognitive functions in Egyptian neuromyelitis optica spectrum disorder","volume":"189","author":"Salama","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2024.105596_bib0056","article-title":"Patient pathway to diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): findings from a multinational survey of 204 patients","author":"Santoro","year":"2023","journal-title":"Neurol. Ther."},{"issue":"6","key":"10.1016\/j.msard.2024.105596_bib0057","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105596_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management [Review]","volume":"13","author":"Sechi","year":"2022","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2024.105596_bib0059","doi-asserted-by":"crossref","first-page":"e1097","DOI":"10.1212\/WNL.0000000000012467","article-title":"Comparison of MRI lesion evolution in different central nervous system demyelinating disorders","volume":"97","author":"Sechi","year":"2021","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.msard.2024.105596_bib0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-0041-1723955","article-title":"Neuropsychological phenotypes of pediatric anti-myelin oligodendrocyte glycoprotein associated disorders: a case series","volume":"52","author":"Tan","year":"2021","journal-title":"Neuropediatrics."},{"issue":"6","key":"10.1016\/j.msard.2024.105596_bib0061","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1590\/0004-282X20130038","article-title":"Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis","volume":"71","author":"Vanotti","year":"2013","journal-title":"Arq. Neuropsiquiatr."},{"issue":"10","key":"10.1016\/j.msard.2024.105596_bib0062","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3174\/ajnr.A4403","article-title":"Gray matter volume reduction is associated with cognitive impairment in neuromyelitis optica","volume":"36","author":"Wang","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.msard.2024.105596_bib0063","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti\u2013myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters","year":"2020","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2024.105596_bib0064","series-title":"Wechsler Memory Scale - Revised","author":"Wechsler","year":"1987"},{"key":"10.1016\/j.msard.2024.105596_bib0065","series-title":"Wechsler Adult Intelligence Scale - Third Edition","author":"Wechsler","year":"1997"},{"issue":"4","key":"10.1016\/j.msard.2024.105596_bib0066","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis spectrum disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.msard.2024.105596_bib0067","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"issue":"14","key":"10.1016\/j.msard.2024.105596_bib0068","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1177\/1352458515576982","article-title":"Cognitive impairment in Chinese neuromyelitis optica","volume":"21","author":"Zhang","year":"2015","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2024.105596_bib0069","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/1352458520964415","article-title":"Brain structural and functional alterations in MOG antibody disease","volume":"27","author":"Zhuo","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2024.105596_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00169","article-title":"Editorial: cognitive disorders in neuroimmunological diseases [Editorial]","volume":"11","author":"Ziemssen","year":"2020","journal-title":"Front. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:41:27Z","timestamp":1738064487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":70,"alternative-id":["S2211034824001755"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105596","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105596"}}